Norbert Suttorp Selected Research

Pneumococcal Pneumonia

1/2021	Krueppel-Like Factor 4 Expression in Phagocytes Regulates Early Inflammatory Response and Disease Severity in Pneumococcal Pneumonia.
1/2020	Neutralizing Complement C5a Protects Mice with Pneumococcal Pulmonary Sepsis.
11/2018	Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia.
1/2018	Sphingosine Kinase 1 Regulates Inflammation and Contributes to Acute Lung Injury in Pneumococcal Pneumonia via the Sphingosine-1-Phosphate Receptor 2.
1/2018	Prognostic and Pathogenic Role of Angiopoietin-1 and -2 in Pneumonia.
1/2018	The cGAS/STING Pathway Detects Streptococcus pneumoniae but Appears Dispensable for Antipneumococcal Defense in Mice and Humans.
1/2018	Peptidoglycan Recognition Protein 3 Does Not Alter the Outcome of Pneumococcal Pneumonia in Mice.
11/2017	Vasculotide reduces pulmonary hyperpermeability in experimental pneumococcal pneumonia.
1/2017	Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling.
4/2016	Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Norbert Suttorp Research Topics

Disease

46	Infections 12/2021 - 01/2004
44	Pneumonia (Pneumonitis) 01/2022 - 07/2006
25	Inflammation (Inflammations) 01/2022 - 02/2006
20	Pneumococcal Pneumonia 01/2021 - 06/2006
18	COVID-19 12/2022 - 01/2020
13	Pneumococcal Infections 01/2021 - 08/2004
10	Sepsis (Septicemia) 01/2020 - 05/2005
7	Malaria 04/2021 - 09/2003
7	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 03/2006
6	Acute Lung Injury 01/2018 - 07/2006
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2009
5	Neoplasms (Cancer) 01/2021 - 09/2009
5	Ventilator-Induced Lung Injury 10/2018 - 01/2010
5	Bites and Stings (Sting) 10/2018 - 01/2012
4	Emphysema 01/2022 - 01/2015
4	Critical Illness (Critically Ill) 01/2022 - 07/2009
4	Disease Progression 10/2021 - 05/2008
4	Hemolysis 11/2019 - 05/2011
4	Edema (Dropsy) 11/2018 - 02/2003
4	Lung Injury 10/2018 - 01/2010
4	Respiratory Hypersensitivity 05/2014 - 08/2006
4	Porcine Reproductive and Respiratory Syndrome (PRRS) 04/2012 - 08/2007
4	Asthma (Bronchial Asthma) 06/2010 - 12/2005
3	Hypothermia 12/2021 - 06/2015
3	Lung Neoplasms (Lung Cancer) 02/2021 - 01/2010
3	Adenocarcinoma of Lung 02/2021 - 01/2010
3	Communicable Diseases (Infectious Diseases) 01/2021 - 05/2007
3	Autolysis 01/2020 - 06/2015
3	Bacterial Pneumonia 01/2018 - 01/2017
3	Body Weight (Weight, Body) 12/2015 - 02/2009
3	Lung Diseases (Lung Disease) 11/2013 - 06/2010
3	Respiratory Insufficiency (Respiratory Failure) 10/2012 - 01/2010
2	Respiratory Tract Infections (Respiratory Tract Infection) 12/2022 - 06/2017
2	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2021
2	Weight Loss (Weight Reduction) 11/2020 - 08/2020

Drug/Important Bio-Agent (IBA)

26	CytokinesIBA 01/2022 - 05/2005
14	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 08/2005
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2010
8	Streptococcus pneumoniae plY proteinIBA 01/2021 - 07/2006
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2004
6	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 07/2006
6	NLR ProteinsIBA 01/2018 - 12/2009
6	InflammasomesIBA 01/2018 - 01/2010
6	AdrenomedullinIBA 04/2014 - 12/2005
5	ProteomeIBA 01/2021 - 02/2016
5	ArtesunateIBA 11/2019 - 05/2011
5	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 12/2009
4	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2020
4	ProcalcitoninIBA 12/2022 - 12/2010
4	Interferon Type IIBA 01/2022 - 11/2011
4	InterferonsIBA 08/2021 - 01/2018
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 02/2005
4	ChemokinesIBA 10/2018 - 03/2007
4	Vasopressins (Vasopressin)IBA 11/2014 - 12/2007
4	AllergensIBA 05/2014 - 08/2006
4	Pattern Recognition ReceptorsIBA 04/2012 - 08/2007
4	Virulence Factors (Pathogenicity Factors)IBA 07/2009 - 08/2005
4	Interleukin-8 (Interleukin 8)IBA 12/2008 - 12/2004
3	C-Reactive ProteinIBA 12/2022 - 12/2010
3	Oxygen (Dioxygen)IBA 01/2022 - 12/2010
3	AntibodiesIBA 01/2022 - 08/2021
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2010
3	InterleukinsIBA 01/2021 - 02/2013
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 04/2008
3	Pharmaceutical PreparationsIBA 11/2019 - 06/2004
3	peptidoglycan recognition proteinIBA 01/2019 - 01/2018
3	sphingosine kinaseIBA 01/2018 - 11/2009
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017 - 12/2004
3	AntigensIBA 01/2017 - 05/2008
3	Interferon-gamma (Interferon, gamma)IBA 05/2015 - 02/2005
3	Atrial Natriuretic Factor (ANF)IBA 11/2014 - 12/2007
3	Interleukin-10 (Interleukin 10)IBA 02/2013 - 02/2006
3	Small Interfering RNA (siRNA)IBA 02/2013 - 12/2008
3	Immunoglobulin E (IgE)IBA 03/2007 - 06/2006
3	p38 Mitogen-Activated Protein KinasesIBA 06/2006 - 02/2003
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2020
2	Troponin T (Troponin T1)IBA 11/2021 - 01/2017
2	Immunoglobulin G (IgG)IBA 08/2021 - 05/2015
2	MicroRNAs (MicroRNA)IBA 04/2021 - 01/2016
2	pembrolizumabIBA 02/2021 - 01/2021
2	Kruppel-Like Factor 4IBA 01/2021 - 02/2013
2	Neutralizing AntibodiesIBA 11/2020 - 08/2020
2	EpitopesIBA 11/2020 - 08/2020
2	Monoclonal AntibodiesIBA 11/2020 - 08/2020
2	CV07-209IBA 11/2020 - 08/2020
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 04/2008
2	N-Acetylmuramoyl-L-alanine Amidase (Autolysin)IBA 01/2020 - 10/2015
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2018 - 01/2018
2	Angiopoietin-1IBA 01/2018 - 11/2017
2	Immunoglobulin A (IgA)IBA 01/2018 - 04/2004

Therapy/Procedure

23	Therapeutics 12/2022 - 07/2006
12	Artificial Respiration (Mechanical Ventilation) 12/2022 - 01/2010
2	Drug Therapy (Chemotherapy) 01/2022 - 11/2020
2	Radiotherapy 01/2022 - 01/2021
2	Palliative Care (Palliative Therapy) 02/2021 - 01/2021
2	Critical Care (Surgical Intensive Care) 01/2021 - 11/2015
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 11/2020 - 01/2015
2	Pleurodesis 01/2020 - 12/2019
2	Catheters 01/2020 - 12/2019
2	Length of Stay 01/2018 - 10/2012